Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Aligos Therapeutics, Inc. (ALGS)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
25 Oct 2023
Nuechterlein Carole
Director, 10% Owner
Aligos Therapeutics, Inc.
(ALGS)
11,025,941
+256%
7,933,601
$0.76
$6,004,149.00
BUY
20 Oct 2020
Versant Venture Capital VI, L.P.
10% Owner
Aligos Therapeutics, Inc.
(ALGS)
862,444
+30%
200,000
$15.00
$3,000,000.00
BUY
20 Oct 2020
Vivo Capital VIII, LLC
10% Owner
Aligos Therapeutics, Inc.
(ALGS)
3,116,658
+21%
550,000
$15.00
$8,250,000.00
BUY
20 Oct 2020
Woiwode Thomas
Director
Aligos Therapeutics, Inc.
(ALGS)
862,444
+30%
200,000
$15.00
$3,000,000.00
BUY
20 Oct 2020
Novo Holdings A/S
10% Owner
Aligos Therapeutics, Inc.
(ALGS)
2,614,563
+8%
200,000
$15.00
$3,000,000.00
Home